The Good News Behind the Recent Rally in These Biotech Stocks (CLSN, MNKD, ARIA, ACAD, INO)

Los Angelas, CA -- (SBWIRE) -- 02/06/2013 -- Celsion Corporation (NASDAQ:CLSN) rose 5.13%, snapping three-day losing streak. The company has recently declared that Zheijang HISUN Pharmaceutical Company (HISUN) does not plan to follow the exclusive option to license ThermoDox® for the Greater China market.

What Should Investors Do With CLSN Now? Find Out Here

MannKind Corporation (NASDAQ:MNKD) advanced 3.42% on below average volume. The company is slated to release its 2012 fourth quarter, full year financial results and other Company developments on Monday, February 11, 2013.

Is MNKD Showing Any Sign of Buy At The Current Market Price? Find Out Here

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) traded higher after disclosing a plan to discuss the Company’s financial results as of December 31, 2012, key corporate objectives and additional corporate activities at 8:30 a.m. (ET) on Monday, February 25, 2013.

Can ARIA Extend Rally? Find Out Here

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) increased 2.45% on below normal volume. The company is going to present at the 15th Annual BIO CEO & Investor Conference to be held on Tuesday, February 12, 2013, at 10:00 a.m. Eastern Time at The Waldorf=Astoria Hotel in New York City.

How Should Investors Trade ACAD After The Recent Volatile Moves? Find Out Here

Inovio Pharmaceuticals, Inc. (NYSE:INO) scored new 1-year high, finishing the day 11.11% up after disclosing a plan to present an overview of the company at RetailInvestorConferences.com to be held on February 7, 2013.

Can INO Extend Gain? If Yes, How Far It Can Go? Find Out Here

DISCLAIMER
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..

Contact:
hotpennystocknews.com
info@hotpennystocknews.com